Skip to main content
SpringerLink
Log in

Prostate cancer incidence as an iceberg

  • COMMENTARY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3(4):524–48. doi:10.1001/jamaoncol.2016.5688.

    Article  Google Scholar 

  2. Massimo Loda LAM, Mittelstadt ML, Van Hemelrijck M, Cotter MB (Eds) Pathology and epidemiology of cancer. Springer, Switzerland 2017.

  3. Mucci LA, Hjelmborg JB, Harris JR, et al. Familial risk and heritability of cancer among twins in Nordic countries. JAMA. 2016;315(1):68–76. doi:10.1001/jama.2015.17703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Eeles RA, Olama AA, Benlloch S, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet. 2013;45(4):385–91. doi:10.1038/ng.2560.

    Article  CAS  PubMed  Google Scholar 

  5. Al Olama AA, Kote-Jarai Z, Berndt SI, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet. 2014;46(10):1103–9. doi:10.1038/ng.3094.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control. 2006;17(8):989–1003. doi:10.1007/s10552-006-0049-z.

    Article  PubMed  Google Scholar 

  7. Valberg M, Grotmol T, Tretli S, et al. Prostate-specific antigen testing for prostate cancer: depleting a limited pool of susceptible individuals? Eur J Epidemiol. 2016;. doi:10.1007/s10654-016-0185-z.

    PubMed  Google Scholar 

  8. Kvale R, Auvinen A, Adami HO, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst. 2007;99(24):1881–7. doi:10.1093/jnci/djm249.

    Article  PubMed  Google Scholar 

  9. Jemal A, Fedewa SA, Ma J, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA. 2015;314(19):2054–61. doi:10.1001/jama.2015.14905.

    Article  CAS  PubMed  Google Scholar 

  10. Jahn JL, Giovannucci EL, Stampfer MJ. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. Int J Cancer. 2015;137(12):2795–802. doi:10.1002/ijc.29408.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev. 2010;19(8):1893–907. doi:10.1158/1055-9965.EPI-10-0437.

    Article  Google Scholar 

  12. Preston MA, Batista JL, Wilson KM, et al. Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer. J Clin Oncol. 2016;34(23):2705–11. doi:10.1200/JCO.2016.66.7527.

    Article  CAS  PubMed  Google Scholar 

  13. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981–90.

    Article  PubMed  Google Scholar 

  14. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71–8. doi:10.1001/jama.291.1.71.

    Article  CAS  PubMed  Google Scholar 

  15. Ciatto S, Gervasi G, Bonardi R, et al. Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991–1994). Eur J Cancer. 2005;41(3):411–5. doi:10.1016/j.ejca.2004.09.030.

    Article  PubMed  Google Scholar 

  16. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121(7):1571–8. doi:10.1002/ijc.22788.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zu K, Mucci L, Rosner BA, et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 2014;106(2):djt430. doi:10.1093/jnci/djt430.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard T.H. Chan School of Public Health, Boston, MA, USA

    Lorelei A. Mucci, Claire H. Pernar, Sam Peisch & Kathryn M. Wilson

  2. Channing Division of Network Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, USA

    Lorelei A. Mucci & Kathryn M. Wilson

  3. Division of Public Health Sciences, University of Iceland, Reykjavík, Iceland

    Lorelei A. Mucci

  4. Department of Epidemiology, Moffitt Cancer Center, Moffitt, FL, USA

    Travis Gerke

Authors
  1. Lorelei A. Mucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claire H. Pernar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sam Peisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Travis Gerke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kathryn M. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorelei A. Mucci.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mucci, L.A., Pernar, C.H., Peisch, S. et al. Prostate cancer incidence as an iceberg. Eur J Epidemiol 32, 477–479 (2017). https://doi.org/10.1007/s10654-017-0265-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-017-0265-8

Keywords

Search

Navigation